Indoco Remedies Limited — Board Meeting, 07-05-2026: Outcome of Board Meeting

Indoco Remedies' board approved Q4 consolidated revenue of ₹455.9 Cr (up 18.7% YoY) & full-year revenue of ₹1792.9 Cr. Q4 net loss was ₹23.68 Cr; full-year net loss ₹98.7 Cr. A dividend of ₹0.20/share for FY26 was proposed. Growth largely driven by International Formulations and API businesses.